Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 12-2006 | 09-2004 | 06-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 37,462 | N/A | 44,782 | 53,312 |
| Marketable Securities | N/A | 106,034 | N/A | 44,821 | 45,244 |
| Receivables | N/A | 51,503 | N/A | 19,730 | 23,340 |
| Inventories | N/A | 27,568 | N/A | 38,232 | 37,102 |
| Income taxes - deferred | N/A | 27,376 | N/A | N/A | N/A |
| Other current assets | 0 | 11,923 | 0 | 0 | 0 |
| TOTAL | $N/A | $270,458 | $N/A | $150,300 | $161,690 |
| Non-Current Assets | |||||
| PPE Net | N/A | 81,223 | N/A | 43,849 | 42,511 |
| Investments And Advances | 0 | 0 | 0 | 3,673 | 3,844 |
| Intangibles | 0 | 27,574 | 0 | 27,665 | 27,761 |
| Other Non-Current Assets | 0 | 137,204 | 0 | 0 | 0 |
| TOTAL | $N/A | $246,001 | $N/A | $75,187 | $74,116 |
| Total Assets | $N/A | $516,459 | $N/A | $225,487 | $235,806 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 69,234 | N/A | 912 | 915 |
| Accounts payable and accrued liabilities | 0 | 16,898 | 0 | 12,641 | 22,312 |
| Accrued Expenses | N/A | 35,838 | N/A | 15,336 | 12,719 |
| TOTAL | $N/A | $160,351 | $N/A | $33,889 | $40,946 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 7,760 | N/A | 7,284 | 7,507 |
| Deferred Revenues | N/A | 26,381 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 32,523 | 0 | 97,978 | 95,000 |
| TOTAL | $N/A | $221,941 | $N/A | $105,262 | $105,275 |
| Total Liabilities | $N/A | $382,292 | $N/A | $139,151 | $146,221 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 58,485 | 58,465 |
| Common Shares | N/A | 591 | N/A | 585 | 584 |
| Retained earnings | N/A | -60,290 | N/A | -98,277 | -94,929 |
| Other shareholders' equity | 0 | -183 | 0 | 0 | 0 |
| TOTAL | $N/A | $134,167 | $N/A | $86,336 | $89,585 |
| Total Liabilities And Equity | $0 | $516,459 | $0 | $225,487 | $235,806 |